Search results
Author(s):
James L Januzzi
Added:
3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved…
View more
Author(s):
Rahul Sakhuja
,
James L Januzzi
Added:
3 years ago
Introduction
With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thus the discernment of new diagnostic and therapeutic strategies to improve prognosis and reduce costs is critical.
The irony is that therapies…
View more
Author(s):
Rahul Sakhuja
,
James L Januzzi
Added:
3 years ago
Introduction
With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thus the discernment of new diagnostic and therapeutic strategies to improve prognosis and reduce costs is critical.1
The irony is that therapies…
View more
Author(s):
Diana Ionescu
,
Caterina Delcea
,
Adrian Catalin Buzea
,
et al
Added:
11 months ago
NT-proBNP in AMI
Author(s):
Shirley Siang Ning Tan
,
Keng Tat Koh
,
Alan Yean Yip Fong
,
et al
Added:
1 year ago
Article
B-type Natriuretic Peptides in the Management of Acute Heart Failure and Acute Coronary Syndromes
Author(s):
Torbjørn Omland
Added:
3 years ago
Article
Amino-terminal Pro-B-type Natriuretic Peptide Testing - Past, Present, and Future Applications
Author(s):
Shanmugam Uthamalingam
,
James L Januzzi
Added:
3 years ago
Article
Author(s):
James L Januzzi
Added:
3 years ago
The use of natriuretic peptide testing has dramatically risen recently, in recognition of the value of these blood tests for assisting in the evaluation of patients with suspected heart failure (HF). B-type natriuretic peptide (BNP) is formed as a consequence of production of a 108-amino-acid precursor peptide that is synthesised within the cardiomyocyte; this 'pro-BNP108' is subsequently cleaved…
View more
Author(s):
Serge Masson
,
Roberto Latini
Added:
3 years ago
Chronic heart failure (HF) is a major cause of death and disability. Predicting patients at risk of death or further cardiovascular events that require more intense monitoring and therapy is clinically challenging. Several factors are associated with increased mortality and morbidity in patients with HF, including age, a history of diabetes mellitus or renal dysfunction, advanced functional…
View more
Author(s):
Christian Müller
Added:
3 years ago
B-type natriuretic peptide (BNP) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) have been shown to be extremely helpful in the diagnosis and management of patients with heart failure (HF). These neurohormones are secreted from both the left and the right cardiac ventricle in response to ventricular volume expansion and pressure overload. BNP and NT-proBNP can be seen as…
View more